Skip to content

Adaptive Biotechnologies ADPT Mrd Business — Goodwill

Other segment segments

Immune Medicine Business
$22.6M0.0%

Similar metrics at other companies

Cleveland-Cliffs logo
CLFOther Businesses — Goodwill
$49M0.0%
Verizon Communications logo
VZBusiness — Goodwill
$3.45B+107%
Xometry, Inc. logo
XMTRUS — Goodwill
$258M0.0%
Oceaneering International logo
OIIManufactured Products Member — Goodwill
$0
Whirlpool logo
WHRMDA Latin America — Goodwill
$29M-3.3%
The Kraft Heinz Company logo
KHCInternational Developed Markets — Goodwill
$1.44B-34.7%

Other financials

Income statement

See full
Revenue$70.9M+35.1%
Gross profit$52.2M+47.1%
Operating income-$19.2M+35.1%
Net income-$20.0M+32.9%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$77.6M+53.2%
Total debt$208.2M-5.6%
Total equity$216.3M+13.6%
Total assets$505.9M-1.0%

Cash flow

See full
Operating cash flow-$9.5M+66.5%
CapEx$796.0K-36.8%
Free cash flow-$10.3M+65.3%

Valuation

See full
Market cap$2.76B+93.6%
Enterprise value$2.89B+78.0%
P/S9.3×+1.8×

Profitability

See full
Gross margin75.3%+12.7pp
Operating margin-15.8%-7.0pp
Net margin-16.8%-7.3pp
FCF margin-10.5%-4.6pp

Returns & leverage

See full
Return on equity-24.4%-9.2pp
Debt / equity-0.2×
Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Adaptive Biotechnologies’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's mrd business — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adaptive Biotechnologies's mrd business — goodwill?
Adaptive Biotechnologies (ADPT) reported mrd business — goodwill of $96.4M in Q4 2025.
What does mrd business — goodwill mean?
This represents the intangible asset value recorded when the MRD business segment was acquired, reflecting the premium paid over the fair value of its net identifiable assets. It serves as a measure of the segment's long-term strategic value and potential for future economic benefits.